SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : sciclone pharmaceuticals
SCLN 11.150.0%Oct 20 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Captain Jack who wrote (770)6/15/2001 9:31:20 PM
From: JEB  Read Replies (2) of 1137
 
Check out GNTA for options, as well. It may be getting ahead of itself here but be warned the cell (Bcl-2) this drug was developed to suppress has a mountain of evidence pointing to the cell as a tumor protector and the trials look very encouraging.

It's an adjuvant drug too, which would compliment Zadaxin in a cocktail use (with a cancer killer drug in a triple therapy approach like is employed against AIDS).

;-)
JEB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News